{"nct_id":"NCT05298254","title":"A Study on the Reactogenicity, Safety, Immune Response, and Efficacy of a Targeted Immunotherapy Against HSV in Healthy Participants Aged 18-40 Years or in Participants Aged 18-60 Years With Recurrent Genital Herpes","status":"COMPLETED","status_verified_date":"2025-08","start_date":"2022-03-07","start_date_type":"ACTUAL","primary_completion_date":"2025-06-12","primary_completion_date_type":"ACTUAL","completion_date":"2025-06-12","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["GSK"]}